Report Detail
Global Low Molecular Weight Heparin (LMWHs) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
- RnM4602102 |
- 20 July, 2024 |
- Global |
- 92 Pages |
- GIR (Global Info Research) |
- Chemical & Material
According to our (Global Info Research) latest study, the global Low Molecular Weight Heparin (LMWHs) market size was valued at USD 348.4 million in 2023 and is forecast to a readjusted size of USD 427.5 million by 2030 with a CAGR of 3.0% during review period.
Low Molecular Weight Heparin (LMWHs) is derived from UFH (Unfractionated heparin) by such processes as chemical degradation, enzymatic depolymerisation and gamma-radiation cleavage.
Natural heparin consists of molecular chains of varying lengths, or molecular weights. Chains of varying molecular weights, from 5000 to over 40,000 Daltons, make up polydisperse pharmaceutical-grade heparin. LMWHs, in contrast, consist of only short chains of polysaccharide. LMWHs are defined as heparin salts having an average molecular weight of less than 8000 Da and for which at least 60% of all chains have a molecular weight less than 8003 Da.
Global Low Molecular Weight Heparin main players are Aspen, Sanofi-aventis, CSBIO, Dongying Tiandong Pharmaceutical, Techdow, etc. Top five companies hold a share above 55%. Europe is the largest market, with a share about 38%.
The Global Info Research report includes an overview of the development of the Low Molecular Weight Heparin (LMWHs) industry chain, the market status of Treatment of Venous Thromboembolism (Enoxaparin, Dalteparin), Complications of Pregnancy (Enoxaparin, Dalteparin), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Low Molecular Weight Heparin (LMWHs).
Regionally, the report analyzes the Low Molecular Weight Heparin (LMWHs) markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Low Molecular Weight Heparin (LMWHs) market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Low Molecular Weight Heparin (LMWHs) market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Low Molecular Weight Heparin (LMWHs) industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (Kiloton), revenue generated, and market share of different by Type (e.g., Enoxaparin, Dalteparin).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Low Molecular Weight Heparin (LMWHs) market.
Regional Analysis: The report involves examining the Low Molecular Weight Heparin (LMWHs) market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Low Molecular Weight Heparin (LMWHs) market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Low Molecular Weight Heparin (LMWHs):
Company Analysis: Report covers individual Low Molecular Weight Heparin (LMWHs) manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Low Molecular Weight Heparin (LMWHs) This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Treatment of Venous Thromboembolism, Complications of Pregnancy).
Technology Analysis: Report covers specific technologies relevant to Low Molecular Weight Heparin (LMWHs). It assesses the current state, advancements, and potential future developments in Low Molecular Weight Heparin (LMWHs) areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Low Molecular Weight Heparin (LMWHs) market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Low Molecular Weight Heparin (LMWHs) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Enoxaparin
Dalteparin
Tinzaparin
Fraxiparine
Market segment by Application
Treatment of Venous Thromboembolism
Complications of Pregnancy
Cardioversion of Atrial Fibrillation/Flutter
Others
Major players covered
Aspen
Sanofi-aventis
Pfizer
Opocrin
CSBIO
Dongying Tiandong Pharmaceutical
Changzhou Qianhong Bio-pharma
Techdow
Yantai Dongcheng Pharmaceutical Group
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Low Molecular Weight Heparin (LMWHs) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Low Molecular Weight Heparin (LMWHs), with price, sales, revenue and global market share of Low Molecular Weight Heparin (LMWHs) from 2019 to 2024.
Chapter 3, the Low Molecular Weight Heparin (LMWHs) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Low Molecular Weight Heparin (LMWHs) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Low Molecular Weight Heparin (LMWHs) market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Low Molecular Weight Heparin (LMWHs).
Chapter 14 and 15, to describe Low Molecular Weight Heparin (LMWHs) sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Low Molecular Weight Heparin (LMWHs)
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Low Molecular Weight Heparin (LMWHs) Consumption Value by Type: 2019 Versus 2023 Versus 2030
- 1.3.2 Enoxaparin
- 1.3.3 Dalteparin
- 1.3.4 Tinzaparin
- 1.3.5 Fraxiparine
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Low Molecular Weight Heparin (LMWHs) Consumption Value by Application: 2019 Versus 2023 Versus 2030
- 1.4.2 Treatment of Venous Thromboembolism
- 1.4.3 Complications of Pregnancy
- 1.4.4 Cardioversion of Atrial Fibrillation/Flutter
- 1.4.5 Others
- 1.5 Global Low Molecular Weight Heparin (LMWHs) Market Size & Forecast
- 1.5.1 Global Low Molecular Weight Heparin (LMWHs) Consumption Value (2019 & 2023 & 2030)
- 1.5.2 Global Low Molecular Weight Heparin (LMWHs) Sales Quantity (2019-2030)
- 1.5.3 Global Low Molecular Weight Heparin (LMWHs) Average Price (2019-2030)
2 Manufacturers Profiles
- 2.1 Aspen
- 2.1.1 Aspen Details
- 2.1.2 Aspen Major Business
- 2.1.3 Aspen Low Molecular Weight Heparin (LMWHs) Product and Services
- 2.1.4 Aspen Low Molecular Weight Heparin (LMWHs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.1.5 Aspen Recent Developments/Updates
- 2.2 Sanofi-aventis
- 2.2.1 Sanofi-aventis Details
- 2.2.2 Sanofi-aventis Major Business
- 2.2.3 Sanofi-aventis Low Molecular Weight Heparin (LMWHs) Product and Services
- 2.2.4 Sanofi-aventis Low Molecular Weight Heparin (LMWHs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.2.5 Sanofi-aventis Recent Developments/Updates
- 2.3 Pfizer
- 2.3.1 Pfizer Details
- 2.3.2 Pfizer Major Business
- 2.3.3 Pfizer Low Molecular Weight Heparin (LMWHs) Product and Services
- 2.3.4 Pfizer Low Molecular Weight Heparin (LMWHs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.3.5 Pfizer Recent Developments/Updates
- 2.4 Opocrin
- 2.4.1 Opocrin Details
- 2.4.2 Opocrin Major Business
- 2.4.3 Opocrin Low Molecular Weight Heparin (LMWHs) Product and Services
- 2.4.4 Opocrin Low Molecular Weight Heparin (LMWHs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.4.5 Opocrin Recent Developments/Updates
- 2.5 CSBIO
- 2.5.1 CSBIO Details
- 2.5.2 CSBIO Major Business
- 2.5.3 CSBIO Low Molecular Weight Heparin (LMWHs) Product and Services
- 2.5.4 CSBIO Low Molecular Weight Heparin (LMWHs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.5.5 CSBIO Recent Developments/Updates
- 2.6 Dongying Tiandong Pharmaceutical
- 2.6.1 Dongying Tiandong Pharmaceutical Details
- 2.6.2 Dongying Tiandong Pharmaceutical Major Business
- 2.6.3 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin (LMWHs) Product and Services
- 2.6.4 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin (LMWHs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.6.5 Dongying Tiandong Pharmaceutical Recent Developments/Updates
- 2.7 Changzhou Qianhong Bio-pharma
- 2.7.1 Changzhou Qianhong Bio-pharma Details
- 2.7.2 Changzhou Qianhong Bio-pharma Major Business
- 2.7.3 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin (LMWHs) Product and Services
- 2.7.4 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin (LMWHs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.7.5 Changzhou Qianhong Bio-pharma Recent Developments/Updates
- 2.8 Techdow
- 2.8.1 Techdow Details
- 2.8.2 Techdow Major Business
- 2.8.3 Techdow Low Molecular Weight Heparin (LMWHs) Product and Services
- 2.8.4 Techdow Low Molecular Weight Heparin (LMWHs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.8.5 Techdow Recent Developments/Updates
- 2.9 Yantai Dongcheng Pharmaceutical Group
- 2.9.1 Yantai Dongcheng Pharmaceutical Group Details
- 2.9.2 Yantai Dongcheng Pharmaceutical Group Major Business
- 2.9.3 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin (LMWHs) Product and Services
- 2.9.4 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin (LMWHs) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.9.5 Yantai Dongcheng Pharmaceutical Group Recent Developments/Updates
3 Competitive Environment: Low Molecular Weight Heparin (LMWHs) by Manufacturer
- 3.1 Global Low Molecular Weight Heparin (LMWHs) Sales Quantity by Manufacturer (2019-2024)
- 3.2 Global Low Molecular Weight Heparin (LMWHs) Revenue by Manufacturer (2019-2024)
- 3.3 Global Low Molecular Weight Heparin (LMWHs) Average Price by Manufacturer (2019-2024)
- 3.4 Market Share Analysis (2023)
- 3.4.1 Producer Shipments of Low Molecular Weight Heparin (LMWHs) by Manufacturer Revenue ($MM) and Market Share (%): 2023
- 3.4.2 Top 3 Low Molecular Weight Heparin (LMWHs) Manufacturer Market Share in 2023
- 3.4.2 Top 6 Low Molecular Weight Heparin (LMWHs) Manufacturer Market Share in 2023
- 3.5 Low Molecular Weight Heparin (LMWHs) Market: Overall Company Footprint Analysis
- 3.5.1 Low Molecular Weight Heparin (LMWHs) Market: Region Footprint
- 3.5.2 Low Molecular Weight Heparin (LMWHs) Market: Company Product Type Footprint
- 3.5.3 Low Molecular Weight Heparin (LMWHs) Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Low Molecular Weight Heparin (LMWHs) Market Size by Region
- 4.1.1 Global Low Molecular Weight Heparin (LMWHs) Sales Quantity by Region (2019-2030)
- 4.1.2 Global Low Molecular Weight Heparin (LMWHs) Consumption Value by Region (2019-2030)
- 4.1.3 Global Low Molecular Weight Heparin (LMWHs) Average Price by Region (2019-2030)
- 4.2 North America Low Molecular Weight Heparin (LMWHs) Consumption Value (2019-2030)
- 4.3 Europe Low Molecular Weight Heparin (LMWHs) Consumption Value (2019-2030)
- 4.4 Asia-Pacific Low Molecular Weight Heparin (LMWHs) Consumption Value (2019-2030)
- 4.5 South America Low Molecular Weight Heparin (LMWHs) Consumption Value (2019-2030)
- 4.6 Middle East and Africa Low Molecular Weight Heparin (LMWHs) Consumption Value (2019-2030)
5 Market Segment by Type
- 5.1 Global Low Molecular Weight Heparin (LMWHs) Sales Quantity by Type (2019-2030)
- 5.2 Global Low Molecular Weight Heparin (LMWHs) Consumption Value by Type (2019-2030)
- 5.3 Global Low Molecular Weight Heparin (LMWHs) Average Price by Type (2019-2030)
6 Market Segment by Application
- 6.1 Global Low Molecular Weight Heparin (LMWHs) Sales Quantity by Application (2019-2030)
- 6.2 Global Low Molecular Weight Heparin (LMWHs) Consumption Value by Application (2019-2030)
- 6.3 Global Low Molecular Weight Heparin (LMWHs) Average Price by Application (2019-2030)
7 North America
- 7.1 North America Low Molecular Weight Heparin (LMWHs) Sales Quantity by Type (2019-2030)
- 7.2 North America Low Molecular Weight Heparin (LMWHs) Sales Quantity by Application (2019-2030)
- 7.3 North America Low Molecular Weight Heparin (LMWHs) Market Size by Country
- 7.3.1 North America Low Molecular Weight Heparin (LMWHs) Sales Quantity by Country (2019-2030)
- 7.3.2 North America Low Molecular Weight Heparin (LMWHs) Consumption Value by Country (2019-2030)
- 7.3.3 United States Market Size and Forecast (2019-2030)
- 7.3.4 Canada Market Size and Forecast (2019-2030)
- 7.3.5 Mexico Market Size and Forecast (2019-2030)
8 Europe
- 8.1 Europe Low Molecular Weight Heparin (LMWHs) Sales Quantity by Type (2019-2030)
- 8.2 Europe Low Molecular Weight Heparin (LMWHs) Sales Quantity by Application (2019-2030)
- 8.3 Europe Low Molecular Weight Heparin (LMWHs) Market Size by Country
- 8.3.1 Europe Low Molecular Weight Heparin (LMWHs) Sales Quantity by Country (2019-2030)
- 8.3.2 Europe Low Molecular Weight Heparin (LMWHs) Consumption Value by Country (2019-2030)
- 8.3.3 Germany Market Size and Forecast (2019-2030)
- 8.3.4 France Market Size and Forecast (2019-2030)
- 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
- 8.3.6 Russia Market Size and Forecast (2019-2030)
- 8.3.7 Italy Market Size and Forecast (2019-2030)
9 Asia-Pacific
- 9.1 Asia-Pacific Low Molecular Weight Heparin (LMWHs) Sales Quantity by Type (2019-2030)
- 9.2 Asia-Pacific Low Molecular Weight Heparin (LMWHs) Sales Quantity by Application (2019-2030)
- 9.3 Asia-Pacific Low Molecular Weight Heparin (LMWHs) Market Size by Region
- 9.3.1 Asia-Pacific Low Molecular Weight Heparin (LMWHs) Sales Quantity by Region (2019-2030)
- 9.3.2 Asia-Pacific Low Molecular Weight Heparin (LMWHs) Consumption Value by Region (2019-2030)
- 9.3.3 China Market Size and Forecast (2019-2030)
- 9.3.4 Japan Market Size and Forecast (2019-2030)
- 9.3.5 Korea Market Size and Forecast (2019-2030)
- 9.3.6 India Market Size and Forecast (2019-2030)
- 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
- 9.3.8 Australia Market Size and Forecast (2019-2030)
10 South America
- 10.1 South America Low Molecular Weight Heparin (LMWHs) Sales Quantity by Type (2019-2030)
- 10.2 South America Low Molecular Weight Heparin (LMWHs) Sales Quantity by Application (2019-2030)
- 10.3 South America Low Molecular Weight Heparin (LMWHs) Market Size by Country
- 10.3.1 South America Low Molecular Weight Heparin (LMWHs) Sales Quantity by Country (2019-2030)
- 10.3.2 South America Low Molecular Weight Heparin (LMWHs) Consumption Value by Country (2019-2030)
- 10.3.3 Brazil Market Size and Forecast (2019-2030)
- 10.3.4 Argentina Market Size and Forecast (2019-2030)
11 Middle East & Africa
- 11.1 Middle East & Africa Low Molecular Weight Heparin (LMWHs) Sales Quantity by Type (2019-2030)
- 11.2 Middle East & Africa Low Molecular Weight Heparin (LMWHs) Sales Quantity by Application (2019-2030)
- 11.3 Middle East & Africa Low Molecular Weight Heparin (LMWHs) Market Size by Country
- 11.3.1 Middle East & Africa Low Molecular Weight Heparin (LMWHs) Sales Quantity by Country (2019-2030)
- 11.3.2 Middle East & Africa Low Molecular Weight Heparin (LMWHs) Consumption Value by Country (2019-2030)
- 11.3.3 Turkey Market Size and Forecast (2019-2030)
- 11.3.4 Egypt Market Size and Forecast (2019-2030)
- 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
- 11.3.6 South Africa Market Size and Forecast (2019-2030)
12 Market Dynamics
- 12.1 Low Molecular Weight Heparin (LMWHs) Market Drivers
- 12.2 Low Molecular Weight Heparin (LMWHs) Market Restraints
- 12.3 Low Molecular Weight Heparin (LMWHs) Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Low Molecular Weight Heparin (LMWHs) and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Low Molecular Weight Heparin (LMWHs)
- 13.3 Low Molecular Weight Heparin (LMWHs) Production Process
- 13.4 Low Molecular Weight Heparin (LMWHs) Industrial Chain
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Low Molecular Weight Heparin (LMWHs) Typical Distributors
- 14.3 Low Molecular Weight Heparin (LMWHs) Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Low Molecular Weight Heparin (LMWHs). Industry analysis & Market Report on Low Molecular Weight Heparin (LMWHs) is a syndicated market report, published as Global Low Molecular Weight Heparin (LMWHs) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Low Molecular Weight Heparin (LMWHs) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
